Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies

Benjamin Thiele, Paul Schmidt-Barbo, Christoph Schultheiss, Edith Willscher, Thomas Weber and Mascha Binder ()
Additional contact information
Benjamin Thiele: Translational Immuno-Oncology, University and University Hospital Basel
Paul Schmidt-Barbo: Translational Immuno-Oncology, University and University Hospital Basel
Christoph Schultheiss: Translational Immuno-Oncology, University and University Hospital Basel
Edith Willscher: Martin-Luther-University Halle-Wittenberg
Thomas Weber: Martin-Luther-University Halle-Wittenberg
Mascha Binder: Translational Immuno-Oncology, University and University Hospital Basel

Nature Communications, 2025, vol. 16, issue 1, 1-4

Date: 2025
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-56395-8 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56395-8

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-56395-8

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().